logo
Ministers slammed over ‘jaw-dropping' NHS negligence claims for poor care

Ministers slammed over ‘jaw-dropping' NHS negligence claims for poor care

Independent13-05-2025

The NHS must do more to reduce 'tragic' incidents of patient harm and cut 'jaw-dropping' payouts for poor care, MPs have warned as costs spiral to a record high.
Compensation for clinical negligence claims cost £2.8bn in 2023-24 – up from £2.6bn the year before – with hundreds of millions paid out in legal fees.
The highest number of claims were for failings in emergency medicine, obstetrics, orthopaedic and general surgery, with maternity care payouts costing the most, totalling £1.1bn last year.
The Department of Health and Social Care has set aside an 'astounding' £58.2bn to cover the potential costs of clinical negligence events occurring before April 2024.
The public accounts committee sounded the alarm on the rise, saying ministers needed to get a grip on NHS finances.
Its chair, Sir Geoffrey Clifton-Brown, said: 'The fact that the government has set aside tens of billions of pounds for clinical negligence payments, its second most costly liability after some of the world's most complex nuclear decommissioning projects, should give our entire society pause.
'It must be a priority of the highest order for the government to reduce tragic incidences of patient harm and lay out a mechanism to reduce legal fees to manage the jaw-dropping costs involved more effectively.'
The most recent NHS data shows 4,076 incidents of severe harm to patients and 4,449 patient deaths were recorded by the NHS in just three months from October to December last year.
And a fifth of last year's record £2.8bn compensation bill – £545m – went to lawyers. That amount is higher than the entire expenditure of the government's legal department, the report found, which totalled £341m in the same year.
In the past five years alone, NHS Resolution, which manages negligence claims, has spent over £12bn on payouts – £2.4bn of which has been spent on claimants' legal fees.
'If we can reduce the leakage of lawyers' fees in the middle, that benefits the whole of the NHS, because there will be more money available for other services,' said Sir Geoffrey,
Hospital chiefs in England warned last week that they have been forced to cut nurse and doctor posts and scale back emergency and maternity care to meet the government 's 'eye watering' savings demands for 2025-26.
The committee challenged the DHSC to set out how it intends to 'reduce tragic incidents of patient harm' and manage the costs of negligence 'more effectively'.
Acknowledging the high cost of payouts for maternity care failings, Sir Geoffrey said the difference between some maternity units and others 'is quite significant'.
He said: 'Obstetrics is an inherently dangerous process, so the line between doing harm and negligence is quite narrow, but the NHS need to look carefully at why some units do get more negligence claims than others.'
MPs on the committee also criticised the DHSC, which they said 'lacks a grip of the financial pressures it faces'.
MPs also raised concerns over the 'uncertainty' surrounding the abolition of NHS England, announced in March, which they said had created 'high levels of uncertainty for patients and for staff'.
They said the DHSC had a 'lack of firm plans' for its closure and reducing its headcount by 50 per cent.
'At the moment, it looks a little bit like shifting the deck chairs on the Titanic. We really want to make sure that this thing is going to work properly,' Sir Geoffrey told The Independent.
'It has been two months since the government's decision to remove what up until now has been seen as a key piece of machinery without articulating a clear plan for what comes next, and the future for patients and staff remains hazy,' he said.
MPs highlighted how some hospitals in England had pushed through unauthorised special exit packages – severance payments which require Treasury sign-off because they are new or contentious, totalling more than £180,000 in 2023/24.
'There remain far too many special severance payments where approval has only been sought after the payment has been made,' they added.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Tesco shoppers warned after supermarket puts new label on popular product
Tesco shoppers warned after supermarket puts new label on popular product

Daily Mirror

time42 minutes ago

  • Daily Mirror

Tesco shoppers warned after supermarket puts new label on popular product

The NHS has issued a stark warning to Tesco shoppers who buy the supermarket's own-brand toilet roll, urging them to 'keep an eye out' and 'contact your GP practice if something doesn't feel right' The NHS is calling on Tesco customers to 'keep an eye out' and to 'contact your GP practice if something doesn't feel right', issuing a stark health warning as Tesco's exclusive Luxury Soft loo rolls now sport the NHS logo on their wrapping. In a bid to ramp up bowel cancer awareness, the partnership between NHS and Britain's leading grocer aims to tap into the regular shopping habits of consumers. Echoing across social media platform X, the NHS broadcasted: "Keep an eye out for our logo on @Tesco toilet roll-78.9 million rolls sold and counting!" The move acts as a timely nudge for shoppers to stay vigilant for early signs of cancer during their bathroom routine. ‌ READ MORE: 'I'm a fashion editor and found an unlikely retailer selling glitzy festival-ready outfits' The NHS is highlighting: "It's a reminder for people to look out for possible signs of cancer when going to the loo. Know what's normal for you and contact your GP practice if something doesn't feel right." ‌ On each pack, just below the NHS logo, is a critical message which reads: "Finding cancer earlier makes it more treatable and can save lives." On this unique packaging, customers will find a checklist of cancer indicators that might be detected in the loo, including changes in bowel movements or blood traces, reports the Express. For an exhaustive list of cancer symptoms, individuals are encouraged to navigate to Signs of bowel cancer include: changes in your poo, such as having softer poo, diarrhoea or constipation that is not usual for you needing to poo more or less often than usual for you blood in your poo, which may look red or black bleeding from your bottom often feeling like you need to poo, even if you've just been to the toilet tummy pain a lump in your tummy bloating losing weight without trying feeling very tired or short of breath – these are signs of anaemia, which can be caused by bowel cancer Should anyone experience symptoms of bowel cancer for more than three weeks, it's imperative to consult a doctor. The NHS offers comfort, stating: "Try not to be embarrassed. The doctor or nurse will be used to talking about these symptoms." If you observe that your stools are black or dark red, or if you're suffering from bloody diarrhoea, it's essential to arrange an urgent GP appointment or seek help from NHS 111. Assistance can be accessed by dialling 111 or using the online service at Cancer manifests in over 200 different varieties and can impact any part of the body, including organs, blood, bone marrow, and the immune system. In some cases, cancer may spread from its original location to other areas of the body, a process referred to as secondary cancer or metastasis. The specific type of cancer dictates the treatment approach. Standard treatments for cancer include surgical removal of the tumour, chemotherapy with drugs designed to eradicate cancer cells, and radiotherapy which employs radiation to target and eliminate cancer cells. Additional treatment methods might encompass immunotherapy, enhancing the immune system's ability to combat cancer, and hormone therapy, aimed at decelerating or stopping the proliferation of cancerous cells. The NHS reassures patients: "You'll be looked after by a team of specialists who will work with you to create a treatment plan that is best for you."

More testing needed for genetic cancer risk as too many women ‘missed', experts say
More testing needed for genetic cancer risk as too many women ‘missed', experts say

The Independent

timean hour ago

  • The Independent

More testing needed for genetic cancer risk as too many women ‘missed', experts say

A new study has revealed that families of some cancer patients are being denied the opportunity to learn about their potential cancer risk due to inconsistencies in genetic testing. Academics have warned that the absence of adequate testing for Lynch syndrome is leaving some cancer patients unaware of their risk of developing other cancers. Lynch syndrome, a rare hereditary condition, elevates the risk of cancers of the bowel, womb, and ovaries. It arises from a gene mutation affecting DNA error correction during replication, potentially leading to uncontrolled cell growth. NHS guidelines stipulate that patients with bowel or womb cancer should undergo tumour assessments for Lynch syndrome markers. The identification of these markers should prompt a referral for genetic testing, confirming the diagnosis and enabling access to support and guidance regarding cancer risks for both the patients and their families. A new study by academics at the University of Edinburgh found not all womb cancer patients are being sent for genetic testing. Researchers examined data on 2,500 womb cancer patients across the UK and Ireland between 2022 and 2023. They found that 91 per cent of tumours were tested for markers of Lynch syndrome, but the test results were not routinely communicated to the wider clinical team. This means that follow-up genetic counselling and blood tests were not always arranged. Of the 181 participants eligible for genetic counselling, just under two-thirds (64 per cent) were referred for appointments, according to the study, which has been published in the journal BMJ Oncology. Researchers said those who were referred faced long waits, resulting in high dropout rates, meaning only 48 per cent of those eligible went on to get the test. Experts from the university said gaps in testing mean some womb cancer patients with Lynch syndrome go undetected. Family members are also left vulnerable to cancer risk, unaware they may have the condition. Dr Neil Ryan, from the University of Edinburgh, who leads the UK audit and research collaborative in obstetrics and gynaecology, said: 'Despite clear guidance and excellent rates of tumour testing, too many women with Lynch syndrome are still being missed because they're not referred for definitive blood testing in a timely way. 'This not only denies them the chance to reduce their future cancer risk but also prevents their relatives from being tested and protected. 'Tumour testing is only cost-effective if it leads to diagnosis — we urgently need to make mainstream testing truly mainstream.'

Hospice plans could see 16 bed unit on Norfolk and Suffolk coast
Hospice plans could see 16 bed unit on Norfolk and Suffolk coast

BBC News

timean hour ago

  • BBC News

Hospice plans could see 16 bed unit on Norfolk and Suffolk coast

A hospice charity has submitted plans to develop an end-of-life care facility in a coastal town 18 years after fundraising Hospice Care launched in 2007, changing its name to East Coast Hospice two years later. In 2023 the charity merged with St Elizabeth Hospice, based in charity says it wants to build a community hospice with 16 beds on its site at Sidegate Lane in Gorleston near Great Newman, chief executive of St Elizabeth Hospice, said: "We are delighted to submit this planning application and share our full plans with the wider community." Plans to build a hospice between Lowestoft and Great Yarmouth have stalled for almost two decades as rival charities competed over plans, sites and community was split over supporting the James Paget University Hospital wanting to build a hospice at the Louise Hamilton Cancer Centre, within its site or the independent East Coast Hospice, which had land and won planning consent for a 10-bed the NHS withdrew its plans, East Coast Hospice merged with St Elizabeth which immediately conducted a feasibility study which found a hospice was needed to help patients in Great Yarmouth and said the previous plans were not suitable to the needs identified in its report, and it appointed Norwich-based LSI proposed unit would feature 16 inpatient beds, an outpatient and community hub for day care and therapies as well as a community café. Roberta Lovick, ambassador for the Louise Hamilton Trust, said: "The strength of our partnership will help us achieve our vision of bringing greater parity to end-of-life care in Great Yarmouth and Waveney."When my daughter Louise died in 1998, I vowed to dedicate my life to improving end-of-life care in this community and across the country, and this project, alongside St Elizabeth Hospice, is a significant step toward that goal."This is something we know the community wants and needs. This community hospice building will make a drastic difference to so many people, improving local end-of-life care, giving people more options and support during their precious remaining time with loved ones." Ms Newman added: "We are delighted to submit this planning application and share our full plans with the wider community."With the invaluable support of Roberta Lovick and the Louise Hamilton Trust, we are in a strong position to develop the community hospice sustainably in a single phase."Ed Garratt, chief executive at Norfolk and Waveney ICB (N&W ICB), said: "This is a hugely welcome development, which aligns with our ambitions to enhance palliative and end-of-life care in our region."I wholeheartedly support this shared commitment from the voluntary sector, NHS and community in working together to improve services for the local population." Follow Norfolk news on BBC Sounds, Facebook, Instagram and X.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store